Applications Published 18 October 2000
Published: 25-May-2001
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
aThe following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Methods and compsns for treating and diagnosing tumours using adenosine receptor activated cells
Link Technology 1043928*Chloroacetamide mixtures with supressed precipitation
BASF 1043929*Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
SmithKline Beecham 1043930*Biostatic coatings for the reduction and prevention of bacterial adhesion
Hydromer 1043931*Methods and systems for the inhibition of vascular hyperplasia
Pharmasonics 1043949*Pharmaceutical compsns comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant
AstraZeneca 1043973*Liposomes containing multiple branch peptode constructions for use against human immunodeficiency virus
Cellpep 1043974*Oral pharnaceutical extended release dosage form
AstraZeneca 1043976*Oral pharmaceutical pulsed release dosage form
AstraZeneca 1043977*Phosphlipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use
Idexx Laboratories 1043978*Compsns for the transdermal and dermal administration of biologically active agents
Pulitzer Italiana 1043979*Method of reducing craving in mammals
Schering 1043980*Fat-binding polymers combined with lipase inhibitors
Geltex Pharmaceuticals 1043981*Lipase inhibiting polymers
Geltex Pharmaceuticals 1043982*Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of the nervous system
Bioabsorbable Concepts 1043983*Pharmaceutical compsns containing bupropion hydrochloride and an inorganic acid stabiliser
American Home Products 1043984*Pharmaceutical compsn containing bupropion hydrochloride and a stabiliser
American Home Products 1043985*Mixture and pharmaceutical compsn comprising Z-4-hydroxytamoxifen and cyclodextrin
Hexal 1043986*Use of serine protease inhibitors to inhibit pathophysiology and neuropathology in a host
Hoffman, Keith; Lynch, Gary 1043987*C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumour activities
Hauser; Johns Hopkins University 1043988*Use of MEK1 inhibitors as protective agents against damage due to ischaemia
The General Hospital Corp 1043989*Pyronin antibacterials, process and novel intermediates thereto
Scriptgen Pharmaceuticals 1043990*Treatment for Alzheimer's disease
Eli Lilly 1043991*$I(R)-procyclidine for treating urinary incontinence
Sepracor 1043992*Use of an aromatase inhibitor in the treatment of decreased androgen to estroge ratio and detrusor urethreal sphincter dyssynergia in men and method to study the dyssynergesia in male rodents
Homos Medical 1043933*Method for treating multiple sclerosis
SmithKline Beecham 1043944*Inhibition of P38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas
Bayer 1043995*Treatment of dyskinesias
Mor-Research Applications 1043996*A dried or frozen pharmaceutical preparation containing a class III antiarrhythmic compound
AstraZeneca 1043997*Use of pyrazolo 3,4-B] pyridine as cyclin dependent kinase inhibitors
Bristol-Myers Squibb 1043998*Novel substituted pyridine compounds useful as modulators of acetylcholine receptors
Merck 1043999*Combination therapy for the treatment of AIDS
Merck 1044000*Integrin receptor antagonists
Merck 1044001*Methods for treatment of disorders of cardiac contractility
Johns Hopkins University 1044002*Compsns and methods for use in ischaemia-reperfusion and endotoxin-related tissue injury
The Trustees of the University of Pennsylvania 1044003*A2A adenosine agonists in combination with a type IV phosphodiesterase inhibitors
The University of Virgina Patent Office 1044004*1,2,4-benzotriazine oxides formulations
Sanofi-Synthelabo 1044005*Use of an antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament to treat a nosocomial microbial infection
Ed Geistlich Sohne 1044006*The use of mannose for combating protein loss enteropathy
SHS Gesellschaft fur Emahrung 1044007*Use of aliphatic polyamines for reducing oxalate
Geltex Pharmaceuticals 1044008*Methods and compsns employing red rice fermentation products
Peking University 1044009*Compsns comprising equisetum and symphytum and methods for the treatment of symptoms associated with mycoplasma infections
Ingram, Teresa 1044010*Pharmaceutical compsn having antitumour activity and process for the preparation thereof
Kim, Song Bae 1044011*Inhibition of angiogenesis by peptide analogues of high molecular weight kinnogen domain 5
Temple University of the Commonwealth System of Higher Education; DuPont Pharmaceuticals; Colman, W Robert; Mousa, A 1044012*Use of a phosphatidinylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers
Board of Regents of the University of Texas System 1044013*Agent for treating allergic or hypersensitivity condition
University of Bristol 1044014*Formulations for amylin agonist peptides
Amylin Pharmaceuticals 1044015*Stabilised insulin compsns
Novo Nordisk 1044016*Supplement for dialysis patients
Johns Hopkins University School of Medicine 1044017*Tumour vaccines for MUC1-positive carcinomas
Max-Delbruck-Centrum fur Molekulare Medizin 1044018*Methods and compsns for desensitisation
Circassa 1044019*Diagnositics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
University of Zurich 1044020*Enhanced transport using membrane disruptive agents
The University of Washington; The University of Massachusetts 1044021*Compsns and methods for targeting delivery of factors
Cytimmune Sciences 1044022*A covalent conjugate of clozapine with a fatty acid and its use for treating schizophrenia
Protarga 1044023*Use of pigemtned reinal epithelial cells for creation of an immune privilege site
Titan Pharmaceuticals 1044024*Nuclear scintigraphic assessment of mucosal function
The University of Virginia Patent Foundation 1044025*Surface and air sterilisation using ultraviolet light and ultrasonic waves
Spectrum Environmental 1044026*Methods, systems and kits for intravascular nucleic acid delivery
Pharmasonics 1044035*Method and apparatus for therapeutic treatment of skin with ultrasound
Klopotek, Peter J 1044038*New derivatives of p-aminophenol and their use
Henkel 1044185*Substituted 2-benzylamino-2-phenylacetamide compounds
Newron Pharmaceuticals 1044186*n-benzyl-3-indenylacetamides derivatives for treating neoplasia
Cell Pathways; The University of Arizona 1044187*Acylated 4-aminopyridene derivatives as pesticides and fungicides
Bayer 1044188*Aryl fused azapolycyclic compounds
Pfizer 1044189*Benylidene pyrazolones, production and use thereof
BASF 1044191*Process for preparing triazole compounds
Zambon 1044192*Process for preparing triazole anti-mycotic compounds
Zambon 1044193*Receptor with affinity for compounds of the oxazoline class
The University of Melbourne 1044194*Isothiazolcarboxylic acid derivatives
Bayer 1044195*Process for the selective oxidation of organic compounds
EI du Pont de Nemours 1044196*New piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides
Klinge Pharma 1044197*Heterocyclic topoisomerase poisons
Rutgers, the State University of New Jersey 1044199*Preparation of terazosin hydrochloride dihydrate
Teva Pharmaceutical Industries 1044200*3-substituted adenines via2-thioxanthines
Euro-Celtique 1044201*Process for the preparation of alpha-oxolactams
Research Corporation Technology 1044204*Chemical acetylation of desacetylcephalosporins
Bristol-Myers Squibb 1044205*Prodrugs of naaladase inhibitors
Guildford Pharmaceuticals 1044206*Novel macrolides
Pfizer Products 1044207*Erythromycin derivatives
Pfizer 1044208*Process for the preparation of 6-O-methyl erythromycin A using 9-hydroxy erythromycin derivatives
Abbott Laboratories 1044209*Human dendriac and braniac-3
Human Genome Sciences 1044210*36 secreted human proteins
Human Genome Sciences 1044211*Human FK506 binding proteins
Human Genome Sciences 1044212*Method of binding albumin and means to be used in the method
Amersham Pharmacia Biotech 1044214*Anti-inflammatory phenylalanine derivatives
Celltech Therapeutics 1044215*DNA molecules encoding human nuclear receptor proteins, NNR7 and NNR7-1
Merck 1044216*SAG: sensitive to apoptosis gene
Warner-Lambert 1044217*Nucelic acids encoding transferrin receptor-like proteins and products related thereto
Cedars-Sinai Medical Centre 1044218*Secreted proteins and polynucleotides encoding them
Genetics Institute 1044220*Novel pectic polysaccharides purified from Angelica gigas nakai and purification method and use as immunostimulating agent thereof
Korea Institute of Science and Technology 1044221*Oxidation in solid state of alcohol configuration containing polymer
Hercules Incorporated 1044222*Process for the continuous production of functionalised polymers
Exxon Chemical Patents 1044223*Method for controlling the division and/or elongation of eukariotic cells
Institut National de la Recherche Agronomique 1044272*Compounds derived from Mycobacterium vaccae and methods for their use
Genesis Research & Development 1044273*Andenoviral vectors with modified capsid proteins
Genzyme Corp 1044274*Mammalian matrix-type metalloprotease
Schering 1044275*Proteases from gram-positive organisms
Genencor International 1044276*Recombinant, active caspases and uses thereof
Thomas Jefferson University 1044277*Biosynthesis of medium chain length polyhydroxyalkanoates
Monsanto 1044278*Lacrimal gland specific emulsions for topical applications to ocular tissue
Allergan Sales 1044678Liposomes
Terumo K 1044679Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate
Beecham Pharmaceuticals 1044680Sustained release carbamazepine formulation.
Taro Pharmaceutical Industries 1044681Process for producing hard capsule.
Shionogi Qualicaps 1044682One-step dispersion method for the microencapsulation of water-soluble substances
Debio Recherche Pharmaceutique 1044683Percutaneously absorbable preparation
Nitto Denko Corp 1044684Farnesol derivatives for morphological transition control over dimorphic fungi
Bio-Giken 1044685 Alcoholic coloured chlorhexidine solution and its manufacturing process
Laboratoires Gilbert 1044686Powders containing tocotrienols, process for producing the same and tablets prepared by compression moulding the same
Fuji Chemical Industry 1044687Method for solubilising pyridonecarboxylic acid, solubiliser therefor, aqueous solution preparations containing pyridonecarboxylic acid and process for producing the same
Senju Pharmaceutical 1044688Solid iodophor preparations and process for producing the same
Fujisawa Pharmaceuticals 1044689Applications of gamma globulin-rich plasma protein mixtures of animal origin and process for the preparation thereof
APC Europe 1044690Use of glycosaminoglycan lipid conjugates for inducing osteogenesis
Tokyo Medical and Dental University 1044691
